Traders Buy High Volume of SIGA Technologies Call Options (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) saw unusually large options trading activity on Wednesday. Stock traders purchased 1,200 call options on the stock. This is an increase of 1,438% compared to the average daily volume of 78 call options.

Institutional Investors Weigh In On SIGA Technologies

Hedge funds have recently made changes to their positions in the company. DekaBank Deutsche Girozentrale bought a new position in shares of SIGA Technologies during the 2nd quarter valued at approximately $40,000. Steward Partners Investment Solutions LLC bought a new stake in SIGA Technologies in the fourth quarter worth $58,000. Bayesian Capital Management LP bought a new stake in SIGA Technologies in the first quarter worth $97,000. Lazard Asset Management LLC purchased a new position in SIGA Technologies during the first quarter worth $105,000. Finally, EntryPoint Capital LLC bought a new position in SIGA Technologies during the first quarter valued at $111,000. 55.40% of the stock is currently owned by hedge funds and other institutional investors.

SIGA Technologies Price Performance

Shares of SIGA stock opened at $8.53 on Friday. The company’s fifty day moving average price is $9.03 and its 200-day moving average price is $8.27. SIGA Technologies has a one year low of $4.26 and a one year high of $12.83. The company has a market capitalization of $608.79 million, a price-to-earnings ratio of 7.75 and a beta of 0.91.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.03 earnings per share for the quarter. The business had revenue of $21.81 million during the quarter. SIGA Technologies had a return on equity of 51.40% and a net margin of 48.55%. During the same quarter in the previous year, the company earned ($0.04) earnings per share. Equities research analysts expect that SIGA Technologies will post 1.01 earnings per share for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.